Falko Busse

Dr. Busse was named President of the Bruker BioSpin Group in May 2018. In this position, Dr. Busse is responsible for management of the global operations of our Bruker BioSpin Group, which manufactures and distributes the company’s Nuclear Magnetic Resonance (NMR) and Electron Paramagnetic Resonance (EPR) technologies in life science, pharmaceutical, industrial and applied research markets as well as the company’s preclinical imaging products and service and lifecycle support for all of BioSpin’s products. Dr. Busse joined Bruker BioSpin in 2015 as Executive Vice President of Research and Development. He assumed responsibility for BioSpin operations, marketing and strategy in early 2017, and was promoted to Deputy BioSpin Group president in October 2017. Prior to joining Bruker, Dr. Busse held successive leadership positions at Philips Healthcare, among them as Chief Technology Officer of the global MRI business, as well as General Manager of growth businesses in image-guided therapy and in data-driven radiology solutions. Dr. Busse holds a Ph.D. in physics from the University of Bonn in Germany, and received further executive training at MIT’s Sloan School of Management.